SCHEMBL19749202

SCHEMBL19749202

COCCN(C)CC(=O)c1cc(C)n(-c2ccc(I)cc2)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
MAPT P10636 4/20 0.48
MITF O75030 3/20 0.48
HTT P42858 3/20 0.48
RAB9A P51151 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
HKDC1 Q2TB90 2/20 0.48
KDM4E B2RXH2 4/20 0.47
LMNA P02545 3/20 0.46
SMN1; SMN2 Q16637 6/20 0.44
RECQL P46063 1/20 0.42
HPGD P15428 3/20 0.42
LSS P48449 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
GLA P06280 1/20 0.41
APOBEC3A P31941 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
NOTUM Q6P988 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19501658 0.91 NOTUM (0.52) ALDH1A1MAPTMITFHTTRAB9A
SCHEMBL6923363 0.89 ALDH1A1 (0.48) ALDH1A1MAPTMITFHTTRAB9A
SCHEMBL17949748 0.89 SMN1; SMN2 (0.55) ALDH1A1MAPTMITFHTTRAB9A
SCHEMBL19749190 0.87 SMN1; SMN2 (0.46) ALDH1A1MAPTMITFHTTRAB9A
SCHEMBL21165190 0.84 SMN1; SMN2 (0.48) ALDH1A1MAPTMITFHTTRAB9A
SCHEMBL19749201 0.77 NOTUM (0.56) ALDH1A1MAPTMITFHTTRAB9A
SCHEMBL19749199 0.75 USP14 (0.47) ALDH1A1MAPTMITFHTTRAB9A
SCHEMBL6922486 0.75 ALDH1A1 (0.45) ALDH1A1MAPTMITFHTTRAB9A
SCHEMBL17949747 0.75 SMN1; SMN2 (0.58) ALDH1A1MAPTMITFHTTRAB9A
SCHEMBL17949836 0.75 SMN1; SMN2 (0.58) ALDH1A1MAPTMITFHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10351568-B2 Compositions and methods for enhancing proteasome activity PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2019-07-16 US disclosed
US-9849135-B2 USP14 inhibitors for treating or preventing viral infections PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-12-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10351568-B2 Compositions and methods for enhancing proteasome activity PSMG3, PSME3, PSMB11 ALDH1A1 4165/4885MAPT 821/4885MITF 2257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.